A clinical pulmonologist sees a pattern emerge and becomes the first to identify vaping-induced lung disease (EVALI) in Utah.

Dr. Dixie Harris from Intermountain Healthcare joins me to talk about how her team helped identify the early cases, the role of telehealth in making that discovery, how we can evaluate and treat our patients with e-cigarette and vaping related lung disease, and much more.

This content is made possible through YOUR support! Thank you to all our subscribing supporters who help fund educational productions like this.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.